News
Transgene Biotek reports consolidated net loss of Rs 0.39 crore in the June 2026 quarter
07-Aug-2026 | 12:59
Sales rise 20.00% to Rs 0.06 crore
Net Loss of Transgene Biotek reported to Rs 0.39 crore in the quarter ended June 2026 as against net loss of Rs 0.43 crore during the previous quarter ended June 2025. Sales rose 20.00% to Rs 0.06 crore in the quarter ended June 2026 as against Rs 0.05 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 0.06 | 0.05 | 20 |
| OPM % | -100.00 | -280.00 | - |
| PBDT | -0.35 | -0.38 | 8 |
| PBT | -0.39 | -0.43 | 9 |
| NP | -0.39 | -0.43 | 9 |
Powered by Capital Market - Live News